AAAAAA

   
Results: 1-16 |
Results: 16
EFFECTIVE SCHEDULES OF EXPOSURE OF MEDULLOBLASTOMA AND RHABDOMYOSARCOMA XENOGRAFTS TO TOPOTECAN CORRELATE WITH IN-VITRO ASSAYS
Authors: PAWLIK CA HOUGHTON PJ STEWART CF CHESHIRE PJ RICHMOND LB DANKS MK
Citation: Ca. Pawlik et al., EFFECTIVE SCHEDULES OF EXPOSURE OF MEDULLOBLASTOMA AND RHABDOMYOSARCOMA XENOGRAFTS TO TOPOTECAN CORRELATE WITH IN-VITRO ASSAYS, Clinical cancer research, 4(8), 1998, pp. 1995-2002
STUDIES OF THE EFFICACY AND PHARMACOLOGY OF IRINOTECAN AGAINST HUMAN COLON-TUMOR XENOGRAFT MODELS
Authors: ZAMBONI WC STEWART CF CHESHIRE PJ RICHMOND LB HANNA SK LUO XL POQUETTE C MCGOVREN JP HOUGHTON JA HOUGHTON PJ
Citation: Wc. Zamboni et al., STUDIES OF THE EFFICACY AND PHARMACOLOGY OF IRINOTECAN AGAINST HUMAN COLON-TUMOR XENOGRAFT MODELS, Clinical cancer research, 4(3), 1998, pp. 743-753
STUDIES OF THE EFFICACY AND PHARMACOLOGY OF IRINOTECAN AGAINST HUMAN COLON-TUMOR XENOGRAFT MODELS
Authors: ZAMBONI WC STEWART CF CHESHIRE PJ RICHMOND LB HANNA SK LUO XL POQUETTE C MCGOVREN JP HOUGHTON JA HOUGHTON PJ
Citation: Wc. Zamboni et al., STUDIES OF THE EFFICACY AND PHARMACOLOGY OF IRINOTECAN AGAINST HUMAN COLON-TUMOR XENOGRAFT MODELS, Clinical cancer research, 4(3), 1998, pp. 743-753
ALTERED IRINOTECAN AND SN-38 DISPOSITION AFTER INTRAVENOUS AND ORAL-ADMINISTRATION OF IRINOTECAN IN MICE BEARING HUMAN NEUROBLASTOMA XENOGRAFTS
Authors: ZAMBONI WC HOUGHTON PJ THOMPSON J CHESHIRE PJ HANNA SK RICHMOND LB LOU XL STEWART CF
Citation: Wc. Zamboni et al., ALTERED IRINOTECAN AND SN-38 DISPOSITION AFTER INTRAVENOUS AND ORAL-ADMINISTRATION OF IRINOTECAN IN MICE BEARING HUMAN NEUROBLASTOMA XENOGRAFTS, Clinical cancer research, 4(2), 1998, pp. 455-462
ALTERED IRINOTECAN AND SN-38 DISPOSITION AFTER INTRAVENOUS AND ORAL-ADMINISTRATION OF IRINOTECAN IN MICE BEARING HUMAN NEUROBLASTOMA XENOGRAFTS
Authors: ZAMBONI WC HOUGHTON PJ THOMPSON J CHESHIRE PJ HANNA SK RICHMOND LB LOU XL STEWART CF
Citation: Wc. Zamboni et al., ALTERED IRINOTECAN AND SN-38 DISPOSITION AFTER INTRAVENOUS AND ORAL-ADMINISTRATION OF IRINOTECAN IN MICE BEARING HUMAN NEUROBLASTOMA XENOGRAFTS, Clinical cancer research, 4(2), 1998, pp. 455-462
PROBENECID ALTERS TOPOTECAN SYSTEMIC AND RENAL DISPOSITION BY INHIBITING RENAL TUBULAR SECRETION
Authors: ZAMBONI WC HOUGHTON PJ JOHNSON RK HULSTEIN JL CROM WR CHESHIRE PJ HANNA SK RICHMOND LB LUO XL STEWART CF
Citation: Wc. Zamboni et al., PROBENECID ALTERS TOPOTECAN SYSTEMIC AND RENAL DISPOSITION BY INHIBITING RENAL TUBULAR SECRETION, The Journal of pharmacology and experimental therapeutics, 284(1), 1998, pp. 89-94
EFFICACY OF SYSTEMIC ADMINISTRATION OF IRINOTECAN AGAINST NEUROBLASTOMA XENOGRAFTS
Authors: THOMPSON J ZAMBONI WC CHESHIRE PJ LUTZ L LUO XL LI YL HOUGHTON JA STEWART CF HOUGHTON PJ
Citation: J. Thompson et al., EFFICACY OF SYSTEMIC ADMINISTRATION OF IRINOTECAN AGAINST NEUROBLASTOMA XENOGRAFTS, Clinical cancer research, 3(3), 1997, pp. 423-431
EFFICACY OF ORAL IRINOTECAN AGAINST NEUROBLASTOMA XENOGRAFTS
Authors: THOMPSON J ZAMBONI WC CHESHIRE PJ RICHMOND L LUO XL HOUGHTON JA STEWART CF HOUGHTON PJ
Citation: J. Thompson et al., EFFICACY OF ORAL IRINOTECAN AGAINST NEUROBLASTOMA XENOGRAFTS, Anti-cancer drugs, 8(4), 1997, pp. 313-322
PROBENECID ALTERS TOPOTECAN (TPT) SYSTEMIC AND RENAL DISPOSITION
Authors: ZAMBONI WC HOUGHTON PJ JOHNSON RK HULSTEIN JL CROM WR CHESHIRE PJ RICHMOND LB STEWART CF
Citation: Wc. Zamboni et al., PROBENECID ALTERS TOPOTECAN (TPT) SYSTEMIC AND RENAL DISPOSITION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 33-33
EVALUATION OF IRINOTECAN IN COMBINATION WITH 5-FLUOROURACIL OR ETOPOSIDE IN XENOGRAFT MODELS OF COLON ADENOCARCINOMA AND RHABDOMYOSARCOMA
Authors: HOUGHTON JA CHESHIRE PJ HALLMAN JD LUTZ L LUO XL LI YL HOUGHTON PJ
Citation: Ja. Houghton et al., EVALUATION OF IRINOTECAN IN COMBINATION WITH 5-FLUOROURACIL OR ETOPOSIDE IN XENOGRAFT MODELS OF COLON ADENOCARCINOMA AND RHABDOMYOSARCOMA, Clinical cancer research, 2(1), 1996, pp. 107-118
POTENTIATION OF 5-FLUOROURACIL-LEUCOVORIN ACTIVITY BY INTERFERON-ALPHA-2A IN COLON ADENOCARCINOMA XENOGRAFTS
Authors: HOUGHTON JA CHESHIRE PJ MORTON CL STEWART CF
Citation: Ja. Houghton et al., POTENTIATION OF 5-FLUOROURACIL-LEUCOVORIN ACTIVITY BY INTERFERON-ALPHA-2A IN COLON ADENOCARCINOMA XENOGRAFTS, Clinical cancer research, 1(1), 1995, pp. 33-40
EFFICACY OF SULOFENUR AND A 2ND-GENERATION DIARYLSULFONYLUREA, ROBENZOFURYL)SULFONYL]-N'-(3,4-DICHLOROPHENYL)UREA (LY295501), AGAINST COLONADENOCARCINOMA XENOGRAFTS
Authors: HOUGHTON PJ CHESHIRE PJ MYERS L LUTZ L TOTH J GRINDEY GB HOUGHTON JA
Citation: Pj. Houghton et al., EFFICACY OF SULOFENUR AND A 2ND-GENERATION DIARYLSULFONYLUREA, ROBENZOFURYL)SULFONYL]-N'-(3,4-DICHLOROPHENYL)UREA (LY295501), AGAINST COLONADENOCARCINOMA XENOGRAFTS, Anti-cancer drugs, 6(2), 1995, pp. 317-323
EFFICACY OF TOPOISOMERASE-I INHIBITORS, TOPOTECAN AND IRINOTECAN, ADMINISTERED AT LOW-DOSE LEVELS IN PROTRACTED SCHEDULES TO MICE BEARING XENOGRAFTS OF HUMAN TUMORS
Authors: HOUGHTON PJ CHESHIRE PJ HALLMAN JD LUTZ L FRIEDMAN HS DANKS MK HOUGHTON JA
Citation: Pj. Houghton et al., EFFICACY OF TOPOISOMERASE-I INHIBITORS, TOPOTECAN AND IRINOTECAN, ADMINISTERED AT LOW-DOSE LEVELS IN PROTRACTED SCHEDULES TO MICE BEARING XENOGRAFTS OF HUMAN TUMORS, Cancer chemotherapy and pharmacology, 36(5), 1995, pp. 393-403
THERAPEUTIC EFFICACY OF THE CYCLOPROPYLPYRROLOINDOLE, CARZELESIN, AGAINST XENOGRAFTS DERIVED FROM ADULT AND CHILDHOOD SOLID TUMORS
Authors: HOUGHTON PJ CHESHIRE PJ HALLMAN JD HOUGHTON JA
Citation: Pj. Houghton et al., THERAPEUTIC EFFICACY OF THE CYCLOPROPYLPYRROLOINDOLE, CARZELESIN, AGAINST XENOGRAFTS DERIVED FROM ADULT AND CHILDHOOD SOLID TUMORS, Cancer chemotherapy and pharmacology, 36(1), 1995, pp. 45-52
EVALUATION OF A NOVEL BIS-NAPHTHALIMIDE ANTICANCER AGENT, DMP-840, AGAINST HUMAN XENOGRAFTS DERIVED FROM ADULT, JUVENILE, AND PEDIATRIC CANCERS
Authors: HOUGHTON PJ CHESHIRE PJ HALLMAN JC GROSS JL MCRIPLEY RJ SUN JH BEHRENS CH DEXTER DL HOUGHTON JA
Citation: Pj. Houghton et al., EVALUATION OF A NOVEL BIS-NAPHTHALIMIDE ANTICANCER AGENT, DMP-840, AGAINST HUMAN XENOGRAFTS DERIVED FROM ADULT, JUVENILE, AND PEDIATRIC CANCERS, Cancer chemotherapy and pharmacology, 33(4), 1994, pp. 265-272
THERAPEUTIC EFFICACY OF THE TOPOISOMERASE-I INHIBITOR PIPERIDINO]-1-PIPERIDINO)-CARBONYLOXY-CAMPTOTHECIN AGAINST HUMAN TUMOR XENOGRAFTS - LACK OF CROSS-RESISTANCE INVIVO IN TUMORS WITH ACQUIRED-RESISTANCE TO THE TOPOISOMERASE-I INHIBITOR 9-DIMETHYLAMINOMETHYL-10-HYDROXYCAMPTOTHECIN
Authors: HOUGHTON PJ CHESHIRE PJ HALLMAN JC BISSERY MC MATHIEUBOUE A HOUGHTON JA
Citation: Pj. Houghton et al., THERAPEUTIC EFFICACY OF THE TOPOISOMERASE-I INHIBITOR PIPERIDINO]-1-PIPERIDINO)-CARBONYLOXY-CAMPTOTHECIN AGAINST HUMAN TUMOR XENOGRAFTS - LACK OF CROSS-RESISTANCE INVIVO IN TUMORS WITH ACQUIRED-RESISTANCE TO THE TOPOISOMERASE-I INHIBITOR 9-DIMETHYLAMINOMETHYL-10-HYDROXYCAMPTOTHECIN, Cancer research, 53(12), 1993, pp. 2823-2829
Risultati: 1-16 |